Patients who previously had Covid-19 appeared to have a lower risk of contracting Covid-19 from the delta variant than those who received Pfizer-BioNTech's Covid-19 vaccine alone, according to a preprint study from Israel published in medRxiv. However, the authors and other health experts caution the study comes with some significant limitations—and doesn't suggest that people should skip vaccination.
As recent poll numbers suggest vaccine hesitancy is at an all-time low, CDC's Advisory Committee on Immunization Practices voted unanimously to recommend the Pfizer-BioNTech Covid-19 vaccine for people age 16 and older and advised that the United States take a risk-based approach to distributing booster shots.
The Department of Education is opening an investigation into five states over their bans on mask mandates in schools, in today's bite-sized hospital and health industry news from the District of Columbia, New York, and Virginia.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.